Elderly subjects in the atorvastatin 80 mg/day group had lower rates of CHD death, nonfatal non-procedure-related MI, and fatal or nonfatal stroke, although the difference did not reach statistical significance.
← all excerpts
Atorvastatin and cardiovascular risk in the elderly--patient considerations.
1
—
—